Contrast-Induced Nephropathy

Definition & Incidence - Kidney Contrast Chaos

• Definition: Acute Kidney Injury (AKI) occurring after intravascular contrast media (CM) administration, characterized by:
  • Serum creatinine ($SCr$) absolute increase $\ge \textbf{0.3 mg/dL}$ OR
  • $SCr$ percentage increase $\ge \textbf{25-50%}$ from baseline.
  • Typically occurs within $\textbf{48-72 hours}$ post-CM exposure.
  • Requires exclusion of other nephrotoxic insults.
• Incidence:
  • General population with normal renal function: <2%.
  • High-risk patients (e.g., pre-existing CKD, diabetes): 10-30%, can reach up to 50%.

⭐ CIN is a significant cause of hospital-acquired AKI, often cited as the third leading cause.

Pathophysiology - How Contrast Harms

• Primary Mechanisms:
  • Direct Tubular Toxicity:
    • Contrast media (CM) directly injures proximal tubular cells.
    • Generation of Reactive Oxygen Species (ROS) → oxidative stress.
    • Osmotic load → tubular cell swelling (osmotic nephrosis).
  • Renal Medullary Hypoxia:
    • Intrarenal vasoconstriction (↓ Renal Blood Flow, RBF), mediated by adenosine, endothelin.
    • Increased blood viscosity.
    • Reduced O₂ delivery to the vulnerable outer medulla (high metabolic activity).
    • Leads to medullary ischemia, inflammation, and Acute Tubular Necrosis (ATN).

⭐ The renal medulla is particularly susceptible to CIN due to its marginal oxygen supply relative to its high metabolic demand for solute transport.

Risk Factors & Stratification - Danger Zones

Prevention Strategies - Shield Up!

• Hydration:
  • Isotonic saline (0.9% NaCl): 1-1.5 mL/kg/h (3-12h pre, 6-24h post).
  • Oral hydration if IV unfeasible. 📌 Mnemonic: "Hydrate right, CIN takes flight!"
• Contrast Media:
  • Use Low-Osmolar (LOCM) or Iso-Osmolar (IOCM).
  • Minimize volume.
• Medications:
  • N-acetylcysteine (NAC): 600-1200 mg PO BID x2d (pre/day of); benefit debated.
  • Hold nephrotoxins (e.g., NSAIDs) 24-48h prior.

⭐ Hold metformin 48h post-contrast if eGFR < 30 mL/min/1.73m² or AKI; restart after stable renal function.

Clinical Features & Management - Rescue & Recovery

• Clinical: Usually non-oliguric AKI.
  • Serum creatinine (SCr) begins to rise 24-48 hours post-contrast.
  • SCr peaks at 3-5 days.
  • SCr typically normalizes within 7-10 days.
  • Urine output is often maintained.
• Management (Rescue & Recovery):
  • Supportive care is the mainstay.
  • Maintain euvolemia; monitor fluid balance carefully.
  • Track SCr, BUN, and electrolytes.
  • Avoid additional nephrotoxic agents (e.g., NSAIDs).
  • Renal Replacement Therapy (RRT) is rarely required, reserved for severe AKI.

⭐ In CIN, serum creatinine characteristically peaks 3-5 days after contrast administration and usually returns to baseline within 7-10 days if no other renal insult occurs.

High‑Yield Points - ⚡ Biggest Takeaways

• CIN is AKI occurring 48-72 hours post-contrast, defined by ↑ serum creatinine (≥0.5 mg/dL or ≥25% from baseline).
• Major risk factors: Pre-existing CKD (eGFR <60 mL/min/1.73m²), diabetes mellitus, dehydration, and large contrast volume.
• Pathogenesis involves direct tubular toxicity and renal vasoconstriction, leading to medullary hypoxia.
• Prevention is paramount: IV hydration (isotonic saline), use low-osmolar or iso-osmolar contrast media, and minimize contrast dose.
• Most cases are transient, non-oliguric, and resolve with supportive care; dialysis is rarely needed.
• Serum creatinine typically peaks at 3-5 days and returns to baseline within 1-3 weeks in most patients.
• Avoid NSAIDs and other nephrotoxic agents around the time of contrast administration in high-risk patients.